Mafenide: Difference between revisions
Jump to navigation
Jump to search
| Line 7: | Line 7: | ||
==Category== | ==Category== | ||
Sulfonamide | |||
==US Brand Names== | ==US Brand Names== | ||
Revision as of 04:52, 9 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]
Overview
Mafenide (INN; usually as mafenide acetate, trade name Sulfamylon) is a sulfonamide-type medication. It was approved by the FDA in 1948.
Category
Sulfonamide
US Brand Names
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Overdosage | Clinical Studies | Dosage and Administration | How Supplied | Labels and Packages